Business Context and Reporting Period
Company: Novartis AG
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: January 18, 2002
Subject: Invitation to the Full Year Results 2001 Presentation
Reporting Period: Full Year 2001
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as an invitation to a presentation where these figures will be disclosed.
Material Changes
No material changes or comparative financial data are included in this filing. The document references "business developments" to be discussed at the upcoming event but contains no specific details.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Executive Committee has scheduled a presentation for the 2001 results and business developments.
Date and Time: Thursday, February 7, 2002, with a prompt start at 2:00 PM (Switzerland time).
Location: Kongresszentrum, Basel Messeplatz 21, Basel, Switzerland.
Access: The presentation will be available via webcast and telephone dial-in. A reply form is included for attendance confirmation.
Key Facts for Investor Verification
- The actual 2001 financial results are not contained in this filing; investors must attend the February 7, 2002 presentation or access the webcast for data.
- The filing is signed by Raymund Breu, Chief Financial Officer.
- Investors should verify the webcast link (http://www.novartis.com/investors/index.shtml) and dial-in codes prior to the event.
- Response to the invitation is requested by February 1, 2002.